KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Christian Grohé, Jens Kollmeier et al.|Translational Lung Cancer Research|2021Cited by 60
Autoimmune disorders and paraneoplastic syndromes in thymomaTorsten Blum, Torsten Bauer, Daniel Misch et al.|Journal of Thoracic Disease|2020Cited by 57
The European initiative for quality management in lung cancer careTorsten Blum, Jean‐Paul Sculier, Anna Rich et al.|European Respiratory Journal|2014Cited by 50
Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancerDaniel Misch, Jens Kollmeier, Torsten Blum et al.|Diagnostic Pathology|2015Cited by 40
Narrow band imaging (NBI) during medical thoracoscopy: first impressionsNicolas Schönfeld, Sebastian R. Ott, C. Schwarz et al.|Journal of Occupational Medicine and Toxicology|2009Cited by 38